|
1) Oppenheim H. Uber eine eigenartige Krampfkrankeheit des kindlichen unt jugendlichen Alters (Dysbasia lordotoca progressiva, dystonia musculrum deformans). Neurol Zentralblat. 1911; 30: 1090-107
|
|
|
|
|
2) Herz E. Dystonia I. Historical review; analysis of dystonic symptoms and physiologic mechanisms involved. Arch Neurol Psychiatr. 1944; 51: 305-18
|
|
|
|
|
|
3) Denny-Brown D. the basal ganglia and their relation to disorders of movement. Oxford Press. 1962. p. 78-80
|
|
|
|
|
|
4) Fahn S, Marsden CD, Calne DB. Classification and investigation of dystonia. In: Marsden CD, Fahn S, editors. Movement Disorders. 2nd ed. London: Butterworths; 1987
|
|
|
|
|
|
5) MOWEMOVE. Dystonia. Overview of Dystonia. http://www.wemove.org/dys
|
|
|
|
|
|
6) Gambarin M, Valente EM, Liverini P, et al. Atypical phenotypes and clinical variability in a large Italian family with DYT1-primary torsion dystonia. Mov Disord. 2006; 21: 1782-4
|
|
|
|
|
7) Risch NJ, Bressman SB, Senthil G, et al. Intragenic Cis and Trans modification of genetic susceptibility in DYT1 torsion dystonia. Am J Hum Genet. 2007; 80: 1188-93
|
|
|
|
|
|
8) Ohta E, Funayama M, Ichinose H, et al. Novel Mutations in the Guanosine Triphosphate Cyclohydrolase 1 Gene Associated With DYT5 Dystonia. Arch Neurol. 2006; 63: 1605-10
|
|
|
|
|
|
9) http://www.bh4.org/biodefdocs/gch1.pd
|
|
|
|
|
|
10) Rainier S, Thomas D, Tokarz D, et al. Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch. Neurol. 2004; 61: 1025-9
|
|
|
|
|
|
11) Tomita H, Nagamitsu S, Wakui K, et al. Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11. 2-q12. 1. Am J Hum Genet. 1999; 65: 1688-97
|
|
|
|
|
|
12) Valente EM, Edwards MJ, Mir P, et al. The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology. 2005; 64: 737-9
|
|
|
|
|
|
13) Grunewald A, Djarmati K, Lohmann-Hedrichi, et al. Phenotypes and genotypes in myoclonus-dystonia: significance of deletion of the entire SGCE gene. Mov Disord. 2007; 22: S137
|
|
|
|
|
|
14) Esapa CT, Waite A, Locke M, et al. SGCE missense mutations that cause myoclonus-dystonia syndrome impair ε-sarucoglycan trafficking to the plasma membrane moduration by ubiquitination and torsinA. Hum Mole Gent. 2007; 16: 327-42
|
|
|
|
|
|
15) de Carvalho Aguiar P, Sweadner KJ, Penniston J, et al. Mutations in the Na(＋)/K(＋)-ATPase alpha-3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron. 2004; 43: 169-75
|
|
|
|
|
|
16) Brashear A, Dobyns WB, de Carvalho Aguiar P, et al. The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. Brain. 2007; 130: 828-35
|
|
|
|
|
|
17) Goto S, Lee LV, Munoz EL, et al. Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism. Ann Neurol. 2005; 58: 7-17
|
|
|
|
|
|
18) Makino S, Kaji R, Ando S, et al. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet. 2007; 80: 393-406
|
|
|
|
|
|
19) Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. New Engl J Med. 2003; 348: 33-40
|
|
|
|
|
|
20) Defazio G, Abbruzzese G, Livrea P, et al. Epidemiology of primary dystonia. Lancet Neurology. 2004; 3: 673-8
|
|
|
|
|
|
21) Konkiewits CE, Gerhard TI, Kamm C, et al. Service based survey of dystonia in Munich. Neuroepidemiology. 2002; 21: 202-6
|
|
|
|
|
|
22) Nutt JG, Muenter MD, Aronson A, et al. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord. 1988; 3: 188-94
|
|
|
|
|